Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

High-dose naloxone, an experimental tool uncovering latent sensitisation: pharmacokinetics in humans

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Enhanced recovery after surgery components and perioperative outcomes: a nationwide observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Use of the GRADE approach in systematic reviews and guidelines

    Research output: Contribution to journalEditorialResearchpeer-review

  3. Chlorhexidine allergy in the perioperative setting: a narrative review

    Research output: Contribution to journalReviewResearchpeer-review

  4. Comparative epidemiology of suspected perioperative hypersensitivity reactions

    Research output: Contribution to journalReviewResearchpeer-review

  1. Continuous EEG Monitoring in a Consecutive Patient Cohort with Sepsis and Delirium

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Simultaneous quantification of high-dose naloxone and naloxone-3-β-d-glucuronide in human plasma by UHPLC-MS/MS

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Transcerebral exchange kinetics of large neutral amino acids during acute inspiratory hypoxia in humans

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Delayed cerebral ischaemia in patients with aneurysmal subarachnoid haemorrhage: Functional outcome and long-term mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Naloxone, an opioid receptor antagonist, is used as a pharmacological tool to detect tonic endogenous activation of opioid receptors in experimental pain models. We describe a pharmacokinetic model linking naloxone pharmacokinetics to its main metabolite after high-dose naloxone infusion.

METHODS: Eight healthy volunteers received a three-stage stepwise high-dose i.v. naloxone infusion (total dose 3.25 mg kg-1). Naloxone and naloxone-3-glucuronide (N3G) plasma concentrations were sampled from infusion onset to 334 min after infusion discontinuation. Pharmacokinetic analysis was performed using non-linear mixed effect models (NONMEM). The predictive performances of Dowling's and Yassen's models were evaluated, and target-controlled infusion simulations were performed.

RESULTS: Three- and two-compartment disposition models with linear elimination kinetics described the naloxone and N3G concentration time-courses, respectively. Two covariate models were developed: simple (weight proportional) and complex (with the shallow peripheral volume of distribution linearly increasing with body weight). The median prediction error (MDPE) and wobble for Dowling's model were -32.5% and 33.4%, respectively. For Yassen's model, the MDPE and wobble were 1.2% and 19.9%, respectively.

CONCLUSIONS: A parent-metabolite pharmacokinetic model was developed for naloxone and N3G after high-dose naloxone infusion. No saturable pharmacokinetics were observed. Whereas Dowling's model was inaccurate and over-predicted naloxone concentrations, Yassen's model accurately predicted naloxone pharmacokinetics. The newly developed covariate models may be used for high-dose TCI-naloxone for experimental and clinical practice.

CLINICAL TRIALS REGISTRATION: NCT01992146.

Original languageEnglish
JournalBritish Journal of Anaesthesia
Volume123
Issue number2
Pages (from-to)e204-e214
ISSN0007-0912
DOIs
Publication statusPublished - Aug 2019

    Research areas

  • Adolescent, Adult, Humans, Male, Naloxone/pharmacokinetics, Narcotic Antagonists/pharmacokinetics, Young Adult

ID: 58926529